Floatz logo

Plasmid Encoded Il-12

Recurrent Vulvar Carcinoma

M.D. Anderson Cancer CentervaccinePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Recurrent Vulvar Carcinoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
HRYZ Biotech Co.
Phase 2B
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Emory University
Phase 2CCC
Nivolumab
National Cancer Institute (NCI)
Phase 2CCC
Ipilimumab
National Cancer Institute (NCI)
Phase 2CCC
Pembrolizumab
Merck Sharp & Dohme LLC
Phase 2CCC

View all 19 →

Same molecule, other indications

Plasmid Encoded Il-12 is also rated in:

human papilloma virus infectionDormant
CCC
Indicative ·
53 / 100
View asset →
metastatic malignant neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →
anal canal carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →